Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$71.56
+4.1%
$69.43
$61.78
$109.04
$14.23B1.022.37 million shs5.39 million shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.38
$2.43
$1.99
$3.80
$99.30M0.6102,072 shs58,049 shs
Nutriband Inc. stock logo
NTRB
Nutriband
$7.76
+3.1%
$6.90
$3.72
$11.78
$93.35M1.13120,350 shs19,756 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$253.97
+0.5%
$260.04
$198.68
$310.00
$9.90B0.41479,849 shs201,840 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
-3.44%-2.13%+5.01%-6.14%-36.66%
InspireMD, Inc. stock logo
NSPR
InspireMD
+0.42%-2.46%0.00%-1.24%-4.42%
Nutriband Inc. stock logo
NTRB
Nutriband
-1.31%-11.41%+11.72%-2.96%-0.66%
Penumbra, Inc. stock logo
PEN
Penumbra
-1.08%-2.40%-4.13%+9.76%+22.27%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$71.56
+4.1%
$69.43
$61.78
$109.04
$14.23B1.022.37 million shs5.39 million shs
InspireMD, Inc. stock logo
NSPR
InspireMD
$2.38
$2.43
$1.99
$3.80
$99.30M0.6102,072 shs58,049 shs
Nutriband Inc. stock logo
NTRB
Nutriband
$7.76
+3.1%
$6.90
$3.72
$11.78
$93.35M1.13120,350 shs19,756 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$253.97
+0.5%
$260.04
$198.68
$310.00
$9.90B0.41479,849 shs201,840 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
-3.44%-2.13%+5.01%-6.14%-36.66%
InspireMD, Inc. stock logo
NSPR
InspireMD
+0.42%-2.46%0.00%-1.24%-4.42%
Nutriband Inc. stock logo
NTRB
Nutriband
-1.31%-11.41%+11.72%-2.96%-0.66%
Penumbra, Inc. stock logo
PEN
Penumbra
-1.08%-2.40%-4.13%+9.76%+22.27%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
2.73
Moderate Buy$84.7718.46% Upside
InspireMD, Inc. stock logo
NSPR
InspireMD
3.00
Buy$4.5089.08% Upside
Nutriband Inc. stock logo
NTRB
Nutriband
1.67
Reduce$13.0067.53% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.89
Moderate Buy$302.8119.23% Upside

Current Analyst Ratings Breakdown

Latest COO, PEN, NTRB, and NSPR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/15/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$310.00 ➝ $300.00
10/13/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$85.00
10/13/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$85.00
10/8/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetHoldBuy$326.00
10/8/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
10/8/2025
Nutriband Inc. stock logo
NTRB
Nutriband
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/8/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldBuy$326.00
10/8/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
10/7/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$300.00 ➝ $285.00
10/1/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$290.00
10/1/2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetSell$64.00
(Data available from 10/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$4.05B3.52$5.62 per share12.74$40.50 per share1.77
InspireMD, Inc. stock logo
NSPR
InspireMD
$7.07M14.05N/AN/A$1.83 per share1.30
Nutriband Inc. stock logo
NTRB
Nutriband
$2.14M43.62N/AN/A$0.58 per share13.38
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B8.29$2.88 per share88.32$29.99 per share8.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$392.30M$2.0335.2516.081.8710.08%9.82%6.54%12/4/2025 (Estimated)
InspireMD, Inc. stock logo
NSPR
InspireMD
-$19.92M-$0.83N/AN/AN/A-413.96%-69.42%-57.68%N/A
Nutriband Inc. stock logo
NTRB
Nutriband
-$10.48M-$2.87N/AN/AN/A-398.29%-85.40%-73.45%12/2/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$3.7667.5450.692.3011.54%11.55%8.76%11/5/2025 (Estimated)

Latest COO, PEN, NTRB, and NSPR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2025Q3 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.90N/AN/AN/A$340.77 millionN/A
9/9/2025Q2 2026
Nutriband Inc. stock logo
NTRB
Nutriband
-$0.17-$2.12-$1.95-$2.12$0.71 million$0.62 million
8/27/2025Q3 2025
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
$1.07$1.10+$0.03$0.49$1.06 billion$1.06 billion
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81$0.86+$0.05$1.15$327.37 million$339.46 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
N/AN/AN/AN/AN/A
InspireMD, Inc. stock logo
NSPR
InspireMD
N/AN/AN/AN/AN/A
Nutriband Inc. stock logo
NTRB
Nutriband
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
0.29
2.12
1.24
InspireMD, Inc. stock logo
NSPR
InspireMD
N/A
6.39
6.05
Nutriband Inc. stock logo
NTRB
Nutriband
0.01
4.78
4.70
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.75
4.04

Institutional Ownership

CompanyInstitutional Ownership
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
24.39%
InspireMD, Inc. stock logo
NSPR
InspireMD
44.78%
Nutriband Inc. stock logo
NTRB
Nutriband
19.70%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%

Insider Ownership

CompanyInsider Ownership
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
1.98%
InspireMD, Inc. stock logo
NSPR
InspireMD
29.72%
Nutriband Inc. stock logo
NTRB
Nutriband
54.09%
Penumbra, Inc. stock logo
PEN
Penumbra
4.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Cooper Companies, Inc. stock logo
COO
Cooper Companies
16,000198.81 million194.87 millionOptionable
InspireMD, Inc. stock logo
NSPR
InspireMD
5041.72 million18.33 millionOptionable
Nutriband Inc. stock logo
NTRB
Nutriband
1012.03 million5.53 millionNot Optionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50039.00 million37.36 millionOptionable

Recent News About These Companies

FY2026 EPS Estimates for Penumbra Reduced by Leerink Partnrs
Penumbra, Inc. $PEN Shares Sold by US Bancorp DE
ITGR or PEN: Which Is the Better Value Stock Right Now?
Wall Street Zen Upgrades Penumbra (NYSE:PEN) to "Buy"
Penumbra (NYSE:PEN) Upgraded at Wall Street Zen
Evercore ISI Remains a Buy on Penumbra (PEN)
Needham Upgrades Penumbra (PEN)
Penumbra (PEN) Stock Trades Up, Here Is Why
Penumbra (NYSE:PEN) Shares Gap Up - What's Next?
9 Analysts Assess Penumbra: What You Need To Know

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cooper Companies stock logo

Cooper Companies NASDAQ:COO

$71.56 +2.80 (+4.07%)
Closing price 04:00 PM Eastern
Extended Trading
$71.92 +0.36 (+0.50%)
As of 05:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

InspireMD stock logo

InspireMD NYSE:NSPR

$2.38 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$2.40 +0.02 (+0.63%)
As of 05:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Nutriband stock logo

Nutriband NASDAQ:NTRB

$7.76 +0.23 (+3.05%)
Closing price 03:59 PM Eastern
Extended Trading
$7.72 -0.04 (-0.58%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

Penumbra stock logo

Penumbra NYSE:PEN

$253.96 +1.36 (+0.54%)
Closing price 03:59 PM Eastern
Extended Trading
$253.24 -0.73 (-0.29%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.